AB
BOLD

Amalgamated Bank’s Audentes Therapeutics, Inc BOLD Stock Holding History

Amalgamated Bank’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,370
Closed -$501K – 1842
2019
Q4 		$501K Buy
8,370
+535
+7% +$20.1K 0.01% 1110
2019
Q3 		$220K Sell
7,835
-65
-0.8% -$2.22K ﹤0.01% 1501
2019
Q2 		$299K Buy
7,900
+2,441
+45% +$93.8K 0.01% 1357
2019
Q1 		$213K Buy
+5,459
New +$157K 0.01% 1479

Amalgamated Bank's BOLD Position: Q1 2020 in Review

Amalgamated Bank sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 8,370 shares — an estimated $501K sold.

Amalgamated Bank first reported a position in BOLD in Q1 2019 and held it in 4 quarters. The position peaked at $501K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Amalgamated Bank reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Amalgamated Bank sold 8,370 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $501K.
  • Amalgamated Bank first reported a position in Audentes Therapeutics, Inc in Q1 2019 and held it in 4 quarters.
  • Amalgamated Bank's Audentes Therapeutics, Inc position peaked at $501K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Amalgamated Bank's 13F filing for Q1 2020, filed 13 May 2020.